These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21569708)

  • 21. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
    Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
    J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large B-cell lymphoma with Hodgkin's features.
    García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of CD19 and lack of miR-223 distinguish extramedullary plasmacytoma from multiple myeloma.
    Yu SC; Chen SU; Lu W; Liu TY; Lin CW
    Histopathology; 2011 May; 58(6):896-905. PubMed ID: 21401705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
    Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
    Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.
    Gordiienko IM; Shlapatska LM; Kovalevska LM; Sidorenko SP
    Exp Oncol; 2016 Jun; 38(2):101-7. PubMed ID: 27356578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connective tissue growth factor is expressed in malignant cells of Hodgkin lymphoma but not in other mature B-cell lymphomas.
    Birgersdotter A; Baumforth KR; Wei W; Murray PG; Sjöberg J; Björkholm M; Porwit A; Ernberg I
    Am J Clin Pathol; 2010 Feb; 133(2):271-80. PubMed ID: 20093237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma.
    Kluiver J; van den Berg A; de Jong D; Blokzijl T; Harms G; Bouwman E; Jacobs S; Poppema S; Kroesen BJ
    Oncogene; 2007 May; 26(26):3769-76. PubMed ID: 17173072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and expression of human B cell-specific transcription factor BACH2 mapped to chromosome 6q15.
    Sasaki S; Ito E; Toki T; Maekawa T; Kanezaki R; Umenai T; Muto A; Nagai H; Kinoshita T; Yamamoto M; Inazawa J; Taketo MM; Nakahata T; Igarashi K; Yokoyama M
    Oncogene; 2000 Aug; 19(33):3739-49. PubMed ID: 10949928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas.
    Ivascu C; Wasserkort R; Lesche R; Dong J; Stein H; Thiel A; Eckhardt F
    Int J Biochem Cell Biol; 2007; 39(7-8):1523-38. PubMed ID: 17433759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [CD99 regulates redifferentiation of classical Hodgkin's lymphoma cell line L428 towards B cells].
    Zhou X; Huang X; Huang Z; Wang Z; Zhao T
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):235-8. PubMed ID: 23443779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant hematopoietic cell lines: in vitro models for the study of primary mediastinal B-cell lymphomas.
    Drexler HG; Ehrentraut S; Nagel S; Eberth S; MacLeod RA
    Leuk Res; 2015 Jan; 39(1):18-29. PubMed ID: 25480038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines.
    Ustaszewski A; Paczkowska J; Janiszewska J; Bernhart SH; Bein J; Russiñol N; Hansmann ML; Chapaprieta V; Martín-Subero JI; Siebert R; Hartmann S; Giefing M
    PLoS One; 2023; 18(3):e0283186. PubMed ID: 36961799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of CD(40) on the in vitro biological behavior of malignant B lymphocytes].
    Shi H; Qi C; Zhuang Y; Gu Z; Yu G; Zhao W; Zhang X
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):420-4. PubMed ID: 12411046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.
    Guan H; Xie L; Wirth T; Ushmorov A
    Oncotarget; 2016 Jun; 7(24):36854-36864. PubMed ID: 27166193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of miR-28 in B cell lymphoma cell lines detected by solution hybridization].
    Xu W; Li JY; Lu FX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):289-92. PubMed ID: 16638199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma.
    Slezak-Prochazka I; Kluiver J; de Jong D; Smigielska-Czepiel K; Kortman G; Winkle M; Rutgers B; Koerts J; Visser L; Diepstra A; Kroesen BJ; van den Berg A
    Oncotarget; 2016 Jan; 7(3):2391-400. PubMed ID: 26497687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.